Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q4 FY22 results · Jan–Mar 2022
Divi's Laboratories reported revenue from operations of ₹2,518.44 crore (up 40.8% from Q4 FY21) and net profit of ₹894.64 crore (up 78.2% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,518.44 | 1,788.19 | +40.8% | 2,493.24 | +1.0% |
| Other income | 52.39 | 23.52 | +122.7% | 16.62 | +215.2% |
| Total income | 2,570.83 | 1,811.71 | +41.9% | 2,509.86 | +2.4% |
| Profit before tax | 1,075.74 | 669.49 | +60.7% | 1,033.66 | +4.1% |
| Net profit for the period | 894.64 | 502.02 | +78.2% | 902.24 | −0.8% |
| EPS, basic (₹) | 33.70 | 18.91 | +78.2% | 33.99 | −0.9% |
| Net margin (%) | 35.5 | 28.1 | 36.2 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,495.03 | 1,718.39 | +45.2% | 2,466.77 | +1.1% |
| Other income | 50.51 | 22.85 | +121.1% | 16.62 | +203.9% |
| Total income | 2,545.54 | 1,741.24 | +46.2% | 2,483.39 | +2.5% |
| Profit before tax | 1,065.69 | 652.18 | +63.4% | 1,036.62 | +2.8% |
| Net profit for the period | 882.96 | 487.93 | +81.0% | 907.22 | −2.7% |
| EPS, basic (₹) | 33.26 | 18.38 | +81.0% | 34.17 | −2.7% |
| Net margin (%) | 35.4 | 28.4 | 36.8 |
Consolidated
- Filed with BSE
- 23 May 2022, 18:57 IST
- Board meeting
- 23 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 May 2022, 18:57 IST
- Board meeting
- 23 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE